SlideShare a Scribd company logo

Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans

•Download as PPT, PDF•
•
PeerVoice
PeerVoice

Sara A. Hurvitz, MD, FACP discusses breast cancer in this CME activity titled "Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans." For the full presentation, please visit us at www.peervoice.com/GJV870.

Health & Medicine
1 of 30
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans

Recommended

Case Study Challenge: Managing FLT3-ITD–Positive AML
Case Study Challenge: Managing FLT3-ITD–Positive AMLCase Study Challenge: Managing FLT3-ITD–Positive AML
Case Study Challenge: Managing FLT3-ITD–Positive AML
PeerVoice
 
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
PeerVoice
 
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
PeerVoice
 
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
PeerVoice
 
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
PeerVoice
 
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
PeerVoice
 
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
PeerVoice
 
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
PeerVoice
 

Recommended

Case Study Challenge: Managing FLT3-ITD–Positive AML
Case Study Challenge: Managing FLT3-ITD–Positive AMLCase Study Challenge: Managing FLT3-ITD–Positive AML
Case Study Challenge: Managing FLT3-ITD–Positive AML
PeerVoice
 
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
The Central Role of the Pathologist in Detecting MET Alterations: Enabling Mu...
PeerVoice
 
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Poten...
PeerVoice
 
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
Differentiating Between BTK Inhibitors in CLL: Same Class, Distinctly Dissimi...
PeerVoice
 
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Ad...
PeerVoice
 
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
Practical Considerations for FLT3 Inhibitors in Acute Myeloid Leukaemia: Opti...
PeerVoice
 
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...
PeerVoice
 
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...
PeerVoice
 
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal HaemoglobinuriaThe Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
PeerVoice
 
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
PeerVoice
 
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
PeerVoice
 
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
PeerVoice
 
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
PeerVoice
 
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
PeerVoice
 
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
PeerVoice
 
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
PeerVoice
 
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
PeerVoice
 
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
PeerVoice
 
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
PeerVoice
 
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
PeerVoice
 
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRCExpert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
PeerVoice
 
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
PeerVoice
 
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
PeerVoice
 
Building a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical PracticesBuilding a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical Practices
PeerVoice
 
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
PeerVoice
 
Radioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPCRadioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPC
PeerVoice
 
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
PeerVoice
 
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
PeerVoice
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 

More Related Content

More from PeerVoice

More from PeerVoice (20)

The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal HaemoglobinuriaThe Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria
 
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...
 
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...
 
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...
 
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...
 
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...
 
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...
 
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...
 
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...
 
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...
 
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...
 
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...
 
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRCExpert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC
 
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...
 
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...
 
Building a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical PracticesBuilding a Better Approach to Obesity Care in Our Clinical Practices
Building a Better Approach to Obesity Care in Our Clinical Practices
 
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...
 
Radioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPCRadioligand Therapy and Therapeutic Sequencing in mCRPC
Radioligand Therapy and Therapeutic Sequencing in mCRPC
 
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...
 
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...
 

Recently uploaded

linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
KavyasriPuttamreddy
 

Recently uploaded (20)

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"Presentació "Advancing Emergency Medicine Education through Virtual Reality"
Presentació "Advancing Emergency Medicine Education through Virtual Reality"
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
The History of Diagnostic Medical imaging
The History of Diagnostic Medical imagingThe History of Diagnostic Medical imaging
The History of Diagnostic Medical imaging
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx